Efficacy of a 0.0584% hydrocortisone aceponate spray in presumed feline allergic dermatitis: An open label pilot study

Veterinary Dermatology

Volumn 23, Issue 1, 2012, Pages

  Schmidt, Vanessa ^a   Buckley, Laura M ^a   Mcewan, Neil A ^a   Rème, Christophe A ^b   Nuttall, Tim J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Virbac SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; DRUG DERIVATIVE; HYDROCORTISONE; HYDROCORTISONE ACEPONATE;

AEROSOL; ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; MALE; OFF LABEL DRUG USE; PILOT STUDY; SKIN ALLERGY; TREATMENT OUTCOME;

AEROSOLS; ANIMALS; CAT DISEASES; CATS; DERMATITIS, ALLERGIC CONTACT; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROCORTISONE; MALE; OFF-LABEL USE; PILOT PROJECTS; TREATMENT OUTCOME;

FELIDAE;

EID: 84855349209     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2011.00993.x     Document Type: Article

References (30)

1. Scott DW, Miller WH, Griffin C. Skin immune system and allergic skin disease. In: Muller and Kirk's Small Animal Dermatology 6th edn. Philadelphia, PA: W. B. Saunders Co., 2001: 543-666.
2. Bardagi M, Fondati A, Fondevila D et al. Ultrastructural study of cutaneous lesions in feline eosinophilic granuloma complex. Veterinary Dermatology 2003; 14: 297-303.
3. Taglinger K, Day MJ, Foster AP. Characterization of inflammatory cell infiltration in feline allergic skin disease. Journal of Comparative Pathology 2007; 137: 211-23.
4. Foster AP, O'Dair HA. Allergy testing for skin disease in the cat: in vivo versus in vitro tests. Veterinary Dermatology 1993; 4: 111-5.
5. Mason KV, Evans AG. Mosquito bite-caused eosinophilic dermatitis in cats. Journal of the American Veterinary Medical Association 1991; 198: 2086-8.
6. Nagata M, Ishida T. Cutaneous reactivity to mosquito bites and its antigens in cats. Veterinary Dermatology 1997; 8: 19-26.
7. White SD, Sequoia D. Food hypersensitivity in cats - 14 cases (1982-1987). Journal of the American Veterinary Medical Association 1989; 194: 692-5.
8. Loewenstein C, Mueller RS. A review of allergen-specific immunotherapy in human and veterinary medicine. Veterinary Dermatology 2009; 20: 84-98.
9. Nuttall TJ, McKeever PJ, Harvey RG. Feline eosinophilic granuloma complex. In: A Colour Handbook of Skin Diseases of the Dog and Cat, 2nd edn. London: Manson Publishing Ltd, 2009: 102-5.
10. Vercelli A, Raviri G, Cornegliani L. The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 cases. Veterinary Dermatology 2006; 17: 201-6.
11. Wisselink MA, Willemse T. The efficacy of cyclosporineA in cats with presumed atopic dermatitis: a double blind, randomized prednisolone-controlled study. Veterinary Journal 2009; 180: 55-9.
12. Noli C, Scarampella F. Prospective open pilot study on the use of ciclosporin for feline allergic skin disease. Journal of Small Animal Practice 2006; 47: 434-8.
13. Latimer KS, Rakich PM, Purswell BJ et al. Effects of cyclosporinA administration in cats. Veterinary Immunology and Immunopathology 1986; 11: 161-73.
14. Beatty J, Barrs V. Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy. Australian Veterinary Journal 2006; 84: 30-5.
15. Last RD, Suzuki Y, Manning T et al. A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporinA for feline atopy. Veterinary Dermatology 2004; 15: 194-8.
16. Robson DC, Burton GG. Cyclosporin: applications in small animal dermatology. Veterinary Dermatology 2003; 14: 1-9.
17. Gregory CR, Madewell BR, Griffey SM et al. Feline leukemia virus-associated lymphosarcoma following renal transplantation in a cat. Transplantation 1991; 52: 1097-9.
18. Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. American Journal of Clinical Dermatology 2002; 3: 47-58.
19. Schackert C, Korting HC, Schafer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo- characterization of drugs with an increased benefit-risk ratio. Biodrugs 2000; 13: 267-77.
20. Bryden SL, Burrows AK, Rème CA et al. Efficacy of a 0.0584% hydrocortisone aceponate spray (Cortavance) for the management of pedal pruritus in atopic dogs: a pilot study. Veterinary Dermatology 2008; 19(suppl. 1): 40-1.
21. Nuttall TJ, Mueller RS, Bensignor E et al. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomized, double blind, placebo-controlled trial. Veterinary Dermatology 2009; 20: 191-8.
22. Nuttall TJ, McEwan NA, Bensignor E et al. Equal efficacy of a 0.0584% hydrocortisone aceponate spray and ciclosporin in treating canine atopic dermatitis. Veterinary Dermatology 2010; 21: 534. (abstract).
23. Rème CA, Dufour P. Effects of repeated topical application of a 0.0584% hydrocortisone aceponate spray on skin thickness in Beagle dogs. International Journal of Applied Research in Veterinary Medicine 2010; 8: 1-6.
24. Bizikova P, Linder KE, Paps J et al. Effect of a novel topical diester glucocorticoid spray on immediate- and late-phase cutaneous allergic reactions in Maltese-beagle atopic dogs: a placebo-controlled study. Veterinary Dermatology 2010; 21: 70-9.
25. Olivry T, DeBoer DJ, Favrot C et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 2010; 21: 233-48.
26. Nuttall TJ, Steen RV, Cawood MI et al. FC-49 Feline Dermatitis Extent and Severity Index: a pilot study. Veterinary Dermatology 2004; 15: 36.
27. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Veterinary Dermatology 2007; 18: 301-8.
28. Olivry T, Marsella R, Iwasaki T et al. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Veterinary Dermatology 2007; 18: 78-86.
29. Favrot C, Linek M, Mueller R et al. Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners. Veterinary Dermatology 2010; 21: 63-9.
30. Linek M, Favrot C. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners. Veterinary Dermatology 2010; 21: 456-62.